|
Status |
Public on May 15, 2019 |
Title |
PAIFCS blood 1 |
Sample type |
genomic |
|
|
Source name |
neuroblastoma
|
Organism |
Homo sapiens |
Characteristics |
usi: PAIFCS tissue: blood gender: male cog risk: high inss stage: 4 mycn status: non-amp ploidy: diploid (=1.0) ploidy value: 1
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA was extracted with Qiagen DNA extraction kit protocol
|
Label |
Cy3, Cy5
|
Label protocol |
Standard Illumina HumanHap550 Genotyping BeadChip v1, v3, v3duo, Human610-Quad v1.0 & HumanOmniExpress-12v1 BeadChip protocol
|
|
|
Hybridization protocol |
Standard Illumina HumanHap550 Genotyping BeadChip v1, v3, v3duo, Human610-Quad v1.0 & HumanOmniExpress-12v1 BeadChip protocol
|
Scan protocol |
Standard Illumina HumanHap550 Genotyping BeadChip v1, v3, v3duo, Human610-Quad v1.0 & HumanOmniExpress-12v1 BeadChip protocol
|
Description |
Genomic DNA extracted from primary neuroblastoma and matched blood samples
|
Data processing |
IDATS were imported into Illumina's Genome Studio, along with pertinent manifest and cluster files for array versions HumanHap550 v1, v3, v3duo, Human610-Quad v1.0 & HumanOmniExpress-12v1
|
|
|
Submission date |
May 14, 2019 |
Last update date |
May 15, 2019 |
Contact name |
Gonzalo Lopez |
Organization name |
Mount Sinai School of Medicine
|
Department |
Genetics and Genomic Sciences
|
Street address |
1399 Park avenue
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10016 |
Country |
USA |
|
|
Platform ID |
GPL6433 |
Series (1) |
GSE131189 |
Structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma |
|